EP300 and cervical carcinoma: As for lncRNA and cervical cancer, we have previously demonstrated that HPV E6 and E7 downregulated lncRNA‐CCDST to enhance cervical cancer oncogenicity by promoting its binding protein DHX9 degradation.[26] Here, we further showed that HPV E6 and E7 upregulated lncTUBA3FP through CBP/p300‐mediated H3K27ac of lncTUBA3FP enhancer, resulting in the high expression of TUBORF encoded by lncTUBA3FP in cervical cancer.